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Abstract Humoral memory is maintained by two types of
persistent cells, memory B cells and plasma cells, which
have different phenotypes and functions. Long-lived
plasma cells can survive for a lifespan within a complex
niche in the bone marrow and provide continuous protec-
tive serum antibody levels. Memory B cells reside in
secondary lymphoid organs, where they can be rapidly
mobilized upon a new antigenic encounter. Surface IgG has
long been taken as a surrogate marker for memory in the
mouse. Recently, however, we have brought evidence for a
long-lived IgM memory B cell population in the mouse,
while we have also argued that, in humans, these same cells
are not classical memory B cells but marginal zone (MZ) B
cells which, as opposed to their mouse MZ counterpart,
recirculate and carry a mutated B cell receptor. In this
review, we will discuss these apparently paradoxical
results.
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Introduction
The T-dependent B cell response starts, after encounter of
antigen and appropriate cognate T cell help, by a germinal
center reaction involving a strong proliferative phase.
Expression of activation-induced cytidine deaminase (AID)
during this reaction allows a series of modiﬁcations of
the BCR, including mutations of the variable regions of the
immunoglobulin genes and isotype switch, shifting the
surface Ig expression from IgM to IgG and IgA. The GC
reaction peaks in the second week, with both IgM
? and
IgG
? centroblasts detectable, and wanes after a few weeks
[1]. Selection of B cells displaying enhanced antigen rec-
ognition takes place in the GC environment, mediated by
antigen–antibody complexes retained by the follicular
dendritic cell network that structures germinal centers. This
selection results in the generation of long-lived plasma cells
and memory B cells with an afﬁnity matured, mutated BCR.
When working on B cell memory, obvious questions
come to mind which, ironically enough, have been around
more or less in the same terms for the last 30 years.
What is the role of antigen in maintaining memory?
It has been proposed by several authors that memory B cells
are maintained by the presence of their cognate antigen [2–
4] and that they could accordingly be continuously stimu-
lated giving rise to short-lived plasma cells that would
contribute to maintain the level of speciﬁc antibodies in
the serum [5]. Conversely, it was shown by the group of
K. Rajewsky, through an experimental setting allowing
memory B cells to acquire a new antigenic speciﬁcity that
memory B cells could survive in a quiescent state in the
absence of antigen [6, 7]. Although this question has never
been approached systematically, it has been inferred that
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123certain antigens such as viral particles may persist in the
organism and entertain long lasting GCs [4].
How do memory B cells respond to a re-encounter
with their cognate antigen?
In most reports, the boost is performed a few weeks after
the priming and triggers an active GC reaction and the
formation of antibody-forming cells (AFC) [8]. However,
in some other settings, AFCs could be observed after a
boost without the formation of GCs [9–11]. Here again, the
analysis of the different protocols used may allow us to
explain these conﬂicting data.
How long does B cell memory last?
While this topic has been thoroughly studied in humans,
few data are available concerning this question in mice, as
sensitive enough models have been developed only
recently [10, 12]. Assuming that the persistence of certain
antigenic structures used for immunization must not be
different in mice and men, it remains striking to see such a
difference in the duration of the B cell memory response
between the two species (around 12 months for mice and
decades for humans).
We will at ﬁrst describe the model we have established
to follow B cell memory in the mouse and confront the
results obtained with recent data from other groups, with
the aim to integrate these different models into a plausible
framework. In the second part, recent data on human
IgM
?IgD
?CD27
? B cells will be discussed, confronting
the germinal center versus marginal zone models for their
ontogeny and function.
IgM memory B cells in the mouse: phenotype
and function
Two layers of IgM and IgG memory in mice
with different effector functions
In order to monitor the fate of B cells in a physiological
situation, we have established a mouse model allowing to
timely and irreversibly mark B cells as they engage in a
germinal center reaction during a T-dependent response
[12]. This was achieved by inserting the tamoxifen
inducible Cre-ERT2 gene at the AID locus, allowing its
expression in centroblasts during the GC reaction. After
backcrossing with the Rosa26-LoxP-EYFP reporter mouse,
injection of tamoxifen coupled with immunization induced
the expression of EYFP in the responding cells. Two
antigens have been used, one in a particulate form, sheep
red blood cells (SRBC), and one in a soluble form, NP-
CGG precipitated with alum, with both antigens injected
intra-peritoneally.
This highly sensitive model, which allowed the follow-
up of memory B cells generated in a precise immune
response for up to 1 year by ﬂow cytometry and confocal
microscopy, revealed new features of B cell memory.
Active germinal centers identiﬁed by GL7 or PNA
staining and containing proliferating IgM
? and IgG1
?
centroblasts could be observed for up to 8–10 months after
two immunizations with SRBC. These centroblasts were
embedded in FDCs in contact with CD4 T cells [12]. Con-
versely, germinal centers waned after 2–3 months after two
immunizations with NP-CGG, as shown previously [13].
Memory B cells were observed up to 12 months after
immunization with SRBC and were composed of two
subsets, an IgM
? and an IgG
? subset. The IgM subset
comprised IgM
?IgD
? and IgM-only sub-populations. The
IgG subset comprises IgG1 cells, which represent the major
fraction of SRBC-speciﬁc switched memory B cells, as
well as other isotypes (Fig. 1). Memory B cells and plasma
cells were located within the spleen in the T cell zone and
in the red pulp, with some cells in the follicles and very few
in the marginal zone (Fig. 1).
Boosting the animal 12 months after two immunizations
with SRBC induced the expansion of all the subsets with
the more pronounced formation of GC B cells and plasma
cells. The animals immunized with NP-CGG displayed an
IgM
? and an IgG
? memory subset 3–4 months after the
two immunizations while their response to a boost, 1 year
after, only induced a small plasma cell response.
Transfer of the different memory subsets 2–6 months
after SRBC immunization in normal, pre-immunized ani-
mals gave strikingly different results. The IgM
? subset,
whether GL7
? or GL7
-, gave rise to centroblasts, with part
of them switching to IgG1, and to a small proportion of
SRBC-speciﬁcIgM
?plasmacells.TheIgG1subset,whether
GL7
? or GL7
-, gave rise to SRBC-speciﬁc IgG1 plasmo-
cytes with some maintenance of the IgG1 memory pool.
There were on average three and six mutations per
sequence in IgM and IgG memory B cells, respectively (a
mutation frequency determined on a 440 bp JH4 intronic
sequence) [12]. This frequency of mutations did not change
much between 2 and 6 months, implying, as previously
shown, that the memory pool is made for a large part
during the peak of the GC reaction [14]. On the contrary,
IgM
? and IgG
? centroblasts showed an increasing amount
of mutations with age, with some IgG sequences displaying
up to 50 mutations at 6 months. Clonal relationships were
found between the different subsets, with some large
expansions of clones in the centroblast population.
In summary, this model revealed the existence of a long-
lived IgM
? memory subset in addition to the classical
IgG
? one. It also uncovered a division of labor involving
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memory T cells [15]. Upon a boost, IgM memory B cells
maintained the central memory pool by going back to GC,
undergoing new rounds of SHM and producing later on a
new batch of IgM and IgG memory B cells. IgG memory B
cells, on the other hand, behaved as effector memory cells
giving rise to antibody secreting cells, with some self-
maintenance capacity. In such sense, both central and
effector memory B cell pool were replenished after a boost
in preparation of a new encounter with the original antigen.
The nature of the antigen also revealed clear differences.
With a particulate antigen like SRBC, a protracted GC
response, albeit with a reduced activity, was observed, and
the mice gave a full response mobilizing all subsets 1 year
after immunization. With a soluble protein like NP-CGG,
GCs disappeared after 2–3 months and there was only a
small plasma cell response after 1 year with no new for-
mation of GCs (see below).
Overall, this model seems to suggest that particulate
antigens give rise to a more durable B cell memory.
Moreover, one could speculate that the centroblasts in
persistent GCs, in which ongoing mutation is taking place,
could feed the memory pool at a low level, giving rise to a
much larger panel of antibody afﬁnities and speciﬁcities
against the original antigen. If one thinks in terms of a
mutating pathogen, such diversity might help to maintain
protection of the host. Assuming that GCs are structures
open to circulating B cells [16], persistent GCs could also
constantly recruit newcomers into the immune response.
On the negative side, the large expansion of some clones
observed in persisting GCs might represent an oncogenic
threat.
IgM memory B cells: controversial issues on effector
functions
Confronting recent publications on B cell memory reveals
striking similarities and differences. M. Shlomchik and his
colleagues, using a mouse model in which NP
? memory B
cells from an anti-NP VH knocked-in mouse were
Fig. 1 Location and phenotype of memory B cell subsets in the
mouse. Transgenic mice bearing the Cre-ERT2 gene inserted at the
AID locus and the ROSA26-loxP-EYFP reporter gene were immu-
nized twice with SRBC at a 1-month interval, with simultaneous
ingestion of tamoxifen [12]. (Upper part) Analysis by confocal
microscopy of a mouse spleen, 2 months after the second SRBC
immunization, using anti-B220, CD4 and EYFP antibodies, localiza-
tion of EYFP
? cells in germinal centers, T cell zone and red pulp is
highlighted. Very few EYFP
? cells are detectable in the marginal
zone that forms the outer ring around B cell follicles. (Lower part)
Flow cytometry analysis of EYFP
?-cells for the markers B220, GL7
(germinal centers, GC), IgM, IgD and IgG1, plasmocytes (PC) being
identiﬁed as B220
-. Reported to the initial EYFP
?-gate, the IgG1
?
population, which includes most of the SRBC-speciﬁc switched cells,
represents 12 % of the initial population
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123transferred into an Ig transgenic animal with an irrelevant
Ag speciﬁcity and boosted, conﬁrmed the presence of an
IgM and IgG memory subset. Moreover, they identiﬁed
among these subsets new markers (PD-L2, CD80, CD73)
whose combinatorial expression indicated a gradient of
memory-like properties [17]. Along the same line,
M. Jenkins and colleagues, using for the primary immuni-
zation the soluble protein phyco–erythrin (PE) precipitated
with alum, also observed long-lived IgG and IgM memory
subsets identiﬁed through the binding of this ﬂuorophore
[10]. Upon a boost, by injection of a large PE dose in
emulsion with complete Freund’s adjuvant 1 year after the
primary immunization, PE-speciﬁc IgG
? memory B cells
expanded considerably and differentiated into PE-speciﬁc
antibody producing cells. Strikingly, while the IgM
?
memory subset was more prominent and more stable than
its IgG
? counterpart, being present at a steady level until
450 days after immunization, it did not react to this robust
antigen boost, and could only give rise to active GCs
containing IgM
? and IgG
? centroblasts when transferred
into a naive animal. As expected, the IgG memory subset
gave rise 5 days after its transfer to switched memory B
cells and plasmocytes whose secreted antibodies prevented
the formation of endogenous GCs in the host. These
authors concluded that the long-lasting IgM memory subset
was inhibited by circulating anti-PE antibodies and hence
represented a low afﬁnity memory B cell pool that could
serve as a reservoir of memory B cells once the level of
circulating antibodies has declined [10]. The phenomenon
of serum inhibition of a B cell response has been reported
some time ago, the most likely explanation being that
speciﬁc high afﬁnity antibodies prevented the immunogen
from gaining access to the B cell receptor [18]. A similar
expansion of PE-speciﬁc antibody producing cells in the
absence of GCs induction, was observed by R. Noelle and
colleagues [11], who used the same PE antigen for the
primary immunization and a minimal amount of soluble
antigen for the boost, several weeks later. Surprisingly, a
similar epitope masking phenomenon had been also
reported during a T-independent response in which it was
shown that memory B cells were in fact present but pre-
vented from responding by the antigen-speciﬁc IgG
antibodies [19].
In summary, for a soluble protein antigen, a boost per-
formed either with a very low amount of antigen at a short
interval after the primary immunization or more potently at
a later time will not mobilize IgM memory B cells and
therefore not induce a GC reaction. It will do so if the boost
is more robust and not too distant from the primary
immunization (6–8 weeks). In all cases, the boost will
induce the differentiation of IgG memory B cells into
AFCs. With particulate antigens such as virus particles or
SRBC, IgM memory B cells will respond to a boost distant
from the primary immunization even once GCs have
mostly disappeared.
Different parameters can thus control the behavior of the
IgM memory subset upon a booster immunization: the time
elapsed between the primary immunization and the boost,
and the dose and type of antigen used. It has been reported
that a different signaling is required to trigger IgM and IgG
memory B cells, both membrane-bound IgM and IgD
bearing a short cytoplasmic tail of 3 amino-acids compared
to the 28 amino-acid tail of membrane-bound IgG [20].
Effectively it was shown that phosphorylation of a tyrosine
in the IgG tail recruited the Grb2 protein, which was
responsible for the enhanced signaling observed upon
antigen stimulation [21]. Moreover, another segment of the
IgG tail seemed to favor oligomerization of the BCR thus
increasing the recruitment of the Syk kinase and the cal-
cium response [22]. It appears therefore that, for soluble
proteins that often behave as monovalent antigens, circu-
lating antibodies will more easily compete out the BCR at
the surface of IgM memory B cells. The differential
response observed with time for the IgM memory subset
could be related to the presence of a residual GC reaction
that would allow IgM memory B cells to be mobilized
faster and to beneﬁt from more potent local help from T
helper follicular cells.
In conclusion, and as opposed to what has been pro-
posed for T cells [23], the initial signaling event sustained
by the B cell may not play such a decisive role in the
generation of memory, taking into consideration that both
soluble protein and particulate antigens will induce the
formation of long-lived IgM and IgG memory subsets. The
protocol of immunization and the type and dose of antigen
and adjuvant used would seem more important for the
efﬁciency of the memory response.
Long-term memory in humans
How is this relevant to the human model, which, despite its
obvious difﬁculties, offers a unique window of observation
for long-term responses? Adult spleen rarely displays
germinal centers, conﬁrming that this organ at the adult
stage is seldom engaged into active T-dependent immune
responses. Conversely, a few residual GCs with a clear
CD38
? B cell population within B cell follicles could be
observed in the spleen of young adults, which evoked the
mark of previous immune responses, due to vaccination or
infections (Fig. 2)[ 24]. B cell memory against certain
vaccines such as smallpox and yellow fever can have an
almost inﬁnite lifespan [25–27]. For a pathogen like
smallpox that has been eradicated in the 70s, one can
assume that such memory B cells have not been boosted by
their cognate antigen since the time of vaccination. It is
also very unlikely that anti-vaccinia memory B cells could
1628 C.-A. Reynaud et al.
123be boosted by cross-reacting orthopoxviruses since we
have never observed any positive reaction against vaccinia
virus with memory B cells of young, non-vaccinated peo-
ple (Huetz et al., in preparation).
What can we learn from these long-lived memory B
cells as far as their generation and behavior in front of a
boost or a persisting antigen? VH genes in long-lived anti-
vaccinia memory B cells carried on average 10–20 muta-
tions, implying that this may reﬂect the formation of the
memory pool during the vaccination protocol (Huetz et al.,
in preparation). In a recent report on memory B cells from
individuals who survived the 1918 inﬂuenza pandemic, and
taking into account that these memory B cells were most
probably boosted by the 1930 cross-reacting inﬂuenza
infection, their VH genes displayed up to 32 mutations [28].
In the case of a persistent infection such as HIV, up to 60
mutations per VH gene could be observed in HIV-speciﬁc
memory B cells [29]. It seems therefore that, as in mice,
humans generate their memory pool at the beginning of the
response with a frequency of mutations in the lower range
as compared to GC centroblasts. Upon a boost, which can
happen some years after, memory B cells display a higher
frequency of mutations implying either that ongoing GCs
have continuously fed hypermutated B cells into the
memory pool and/or that IgM (and possibly some IgG)
memory B cells have gone back to GCs to undergo a new
round of SHM [30].
The fact that these memory B cells can remain in the
spleen throughout life ready to react to their cognate
antigen remains a puzzling biological phenomenon. It has
been proposed, according to their in vitro properties, that
memory B cells could proliferate in vivo and give rise to
plasmocytes under bystander stimulations generated by
unrelated immune responses [31]. It is difﬁcult to imagine
that such long-lasting memory could be maintained for a
lifetime by constant stimulation, considering the number of
cell divisions this would imply. Conversely, one could
imagine for these memory B cells a quiescent state in a
privileged niche in which they would be protected from the
surrounding milieu. This status could then be reminiscent
of what has been proposed for naive T cells in which an
inaccessible compact chromatin prevents any cytokine
stimulation unless the antigen receptor is speciﬁcally
stimulated [32].
Human IgM B cells with a mutated Ig receptor:
marginal zone B cells, IgM memory or B1 cells?
The human and mouse B cell compartment are not easily
comparable, with species-speciﬁc differences in terms of
surface markers (e.g., CD38, CD27) and proportion of
effector subsets. Among both splenic and blood B cells in
humans, around 70 % of cells are naive CD27
- B cells and
30 % are CD27
? B cells which are composed equally of
switched B cells (15 %) and IgM
?IgD
? B cells (15 %),
with IgM-only B cells representing a minor population
(1 %) [33, 34].
The marginal zone (MZ) B cell population could be a
paradigmatic example of such divergences. In mice, it is
widely accepted that MZ B cells are a separate lineage,
along which immature B cells engage following a complex
Fig. 2 Active and residual
germinal centers in human
spleen. Germinal centers were
analyzed by confocal
microscopy of two spleen
samples, one from a 4-year-old
child, one from a young adult.
The IgD marker was used,
together with CNA.42 that
marks follicular dendritic cells
(FDC) throughout their
development, and CD55 that
marks FDCs in reactive
lymphoid tissues [59]. CD38
marks GC B cells. Residual GCs
can be found at a low frequency
in the spleen of young adults,
whereas germinal centers are
always numerous and prominent
in spleen samples from young
children
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123array of signals: among those are signals triggered by the
Notch2 pathway, tonic signaling from the BCR, signals
mediated by survival factors and through distinct NF-jB
activators (e.g., the MALT1-Bcl10-CARD11 complex)
[35]. Mouse MZ B cells bear an unmutated BCR, reside in
the splenic marginal zone and do not recirculate, and
respond rapidly to blood borne T-independent antigens,
giving rise to IgM and IgG3 antibody-secreting cells. In
humans, IgM
?IgD
?CD27
? B cells present a similar sur-
face phenotype (IgM
highIgD
lowCD21
highCD23
-CD1c
high)
and reside in the marginal zone of the spleen, but they carry
a mutated Ig receptor and are recirculating [36].
The presence of somatic mutations in the Ig genes of
this subset has nevertheless fostered an alternate interpre-
tation on the origin of IgM
?IgD
?CD27
? B cells, which
would accordingly be the result of a T-dependent response
and represent IgM memory B cells that exited the germinal
center reaction prior to isotype switch. We have reviewed
recently the developmental and functional characteristics
of human marginal zone B cells that led us to propose that
they may constitute a separate B cell diversiﬁcation path-
way [34], and, on the other side, a thorough critical
evaluation of these arguments has been developed by
Tangye and colleagues [37].
Molecular footprints of a germinal center experience
in the IgM
?IgD
?CD27
? B cell subset
Recently, a paper from the group of R. Ku ¨ppers has
brought solid arguments for the existence of a germinal
center-derived IgM B cell population in human adult blood
[38], which, together with the parallel description by our
group of long-lasting antigen-speciﬁc IgM B cells in the
mouse, strongly shifted the balance toward the IgM
memory proposition. In this paper, a thorough analysis of
clonal relationships through CDR3-speciﬁc ampliﬁcation
identiﬁed around one tenth of randomly selected V-D-J
junctions from switched B cells as being present within the
IgM
?IgD
?CD27
? compartment, based on a sample size
that represent 1–2 % of total blood. The second argument
was the presence of mutations in the BCL6 gene in
IgM
?IgD
?CD27
? cells, a gene activated during the ger-
minal center reaction and preventing the premature
detection of AID-induced DNA lesions through transcrip-
tional repression of DNA damage response genes [39].
However, whatever the site where diversiﬁcation of the
IgM
?IgD
?CD27
? subset may take place, it is not unrea-
sonable to assume that a similar BCL6-mediated control
might be required outside the strict germinal center
response to allow for mutation accumulation and to prevent
DNA damage-induced apoptosis.
While these data obviously establish a direct ﬁliation
between (at least some) IgM
?IgD
?CD27
? and switched B
cells in adult blood, should we conclude that the existence
of an IgM memory compartment accounts for all the
properties of the IgM
?IgD
?CD27
? subset, both in spleen
and blood, in adults and in infants? We would like to brieﬂy
summarize some of the recent data, most of which concern
developmental/differentiation aspects, which clearly docu-
ment a distinct behavior of the IgM
?IgD
?CD27
? subset
compared to switched memory B cells.
Distinct repertoire diversiﬁcation of the various B cell
subsets during B cell ontogeny in infants
IgM
?IgD
?CD27
? and switched B cells develop in parallel
in infants (Fig. 3 and [34]). T-dependent germinal center
responses appear soon after birth, while immune responses
to T-independent antigens remain defective during the ﬁrst
years of life. Up to 3 years of age, germinal center B cells
can represent up to 20 % of the total splenic B cell popu-
lation, a value indicative of the strong immune activation
induced by childhood vaccinations [34]. We took advan-
tage of this functional dissociation to analyze the
Fig. 3 Ontogeny of spleen CD27
? subsets and Ig gene mutations.
Spleen samples from one infant at 8 months, three children around
2 years of age and two around 4 years, together with three adults,
were analyzed for the proportion of IgM
?IgD
?CD27
? (D
?27
?) and
switched (D
-27
?) B cell subsets among total splenic B cells, the Ig
mutation frequency (estimated on a 341 bp fragment from the
rearranged JH4–JH5 intron), and the proportion of unmutated
sequences among them ([40] and Descatoire et al., in preparation)
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123complexity of the repertoire of various B cell subsets from
blood or spleen of young children. Using CDR3 spectra-
typing and sequencing of speciﬁc VH rearrangements with
deﬁned CDR3 sizes, we were able to show that the rep-
ertoire of IgM
?IgD
?CD27
? B cells was very large, like
the one of naive B cells, and displayed no clonal ampli-
ﬁcation, hallmarks of antigen-induced activation and
selection, whether mutated or unmutated sequences were
analyzed (see below) (Fig. 4)[ 40]. By contrast, the rep-
ertoire of switched B cells, either in blood or in spleen,
appears much more restricted. The presence of abundant
germinal centers in these spleen samples allowed the
speciﬁc analysis of GC B cells, both at the switched and
at the early IgM expressing stages (Fig. 4). Most strik-
ingly, repertoire restriction and clonal ampliﬁcation were
already manifest at the IgM
? germinal center stage,
making unlikely a direct ﬁliation between a population
displaying antigen-mediated selection and a population
that lacks such imprint [40].
A marked difference was also observed in the ontogeny
of mutations between splenic IgM
?IgD
?CD27
? and swit-
ched B cells (Fig. 3)[ 40]. While most of Ig sequences from
switched B cells harbored mutations, about half of the
IgM
?IgD
?CD27
? VH sequences remain unmutated during
the ﬁrst 2 years of life, revealing a much slower accumu-
lation of mutations during early development, in spite of
the early acquisition of a CD27 marker.
Distinct ontogeny of IgM
?IgD
?CD27
? B cells
during recovery from B cell depleting therapies
B cell depleting therapies mediated by anti-CD20 anti-
bodies (Rituximab) are now used to treat a number of
autoimmune diseases. Such treatments allowed the follow-
up of B cell recovery in ‘‘milder’’ conditions as compared
to the treatment of lymphomas that include a general
aplasia induced by the drastic concurrent chemotherapy.
Such analyses have delineated new intermediates in the B
Fig. 4 Heavy-chain CDR3 spectratyping of blood and splenic subsets
from young children. Blood and spleen samples at the indicated ages
were sorted into naive (IgD
?CD27
-), IgM
?IgD
?CD27
?, and
switched (IgD
-CD27
?) subsets, as well as into germinal center
(GC) B cells (CD24
-CD38
?) for the 8-months spleen sample.
Spectratyping for the V3-15 or the V5-51 genes was performed using
l or c primers, according to the subset analyzed. Increasing CDR3
sizes are represented from left to right. A marked reduced diversity in
CDR3 sizes is observed for switched cells and is already apparent at
the IgM
? germinal center stage, which was conﬁrmed by sequencing
for some CDR3 peaks [40]. In spite of a large size distribution similar
to naive cells, IgM
?IgD
?CD27
? cells always display a 1–2 amino
acids shift in average CDR3 sizes, a phenotype also described for
mouse marginal zone B cells [60]
Human and mouse IgM memory 1631
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[41]. They have also revealed a slow recovery of the
CD27
? B cell fraction in the blood, persisting several years
after treatment [42, 43]. Interestingly, this delayed recon-
stitution appeared more pronounced for the IgM
?IgD
?
CD27
? subset, and affected as well the Ig mutation fre-
quency that failed to reach the level of healthy adults over
the 6-year period of the study [43, 44]. It remains to
uncover what are the factors affecting the B cell recovery
process: the presence of a mature adult microenvironment,
a lower impact of antigenic challenges mediated by vac-
cinations, a long-lasting disturbance of immune
interactions generated by previous treatments, like cortic-
oids, or even a protracted impact of the anti-CD20
depleting agent. It nevertheless establishes that, like during
normal ontogeny, the acquisition of somatic mutations in
the IgM
?IgD
?CD27
? subset is substantially dissociated
from those accumulating in switched memory B cells.
A role for Toll-like receptors in the ontogeny
and homeostasis of IgM
?IgD
?CD27
? B cells
The marginal zone lineage branches at the transitional/
immature stage of B cell development, whereas IgM-
memory B cells are formed during activation of naive B
cells. Previous works from the groups of G. Kelsoe and
T. Imanishi-Kari have shown that inﬂammation and/or
TLR signals can drive a T-independent proliferation and
accumulation of somatic mutations in immature B cells,
which were shown to express a basal level of AID [45, 46].
A similar observation was made recently by R. Carsetti and
colleagues for human B cells: activation of immature B
cells from cord blood through TLR9 signaling was shown
to induce plasmacytic differentiation and isotype switch, as
well as proliferation of a subset of these cells accompanied
by the acquisition of marginal zone markers (CD27
?,
CD24
?, CD38
-) and a low level of somatic mutation [47,
48]. Like in the mouse model, these authors proposed that
signals triggered by external bacterial antigens may drive
an innate-like response of Ig secretion and early Ig gene
diversiﬁcation after birth, creating a ﬁrst line of
defense against invading bacteria. These cells would then
throughout life ensure protection against further infections.
Whereas the relevance of this process to in vivo B cell
differentiation remains to be demonstrated, it highlights
anyway a striking T-independent diversiﬁcation pathway
outside classical germinal center activation.
We have taken a different approach to study the role of
TLR signals in the human B cell lineage, through the
analysis, in collaboration with the group of J.-L. Casanova,
of patients deﬁcient for essential mediators of the TLR
signaling pathway: MyD88, IRAK4 (which both affects
signaling through all TLRs except TLR3), and Unc93B
(which only affects the proper endosomal localization of
nucleic acid sensors, TLR3, 7, 8 and 9) [49–51]. A marked
reduction of IgM
?IgD
?CD27
? B cells in presence of a
normal switched subset was observed in the case of
IRAK4- and MyD88-deﬁcient children and young adults
while no speciﬁc alteration was observed in Unc93B-
deﬁcient patients, with normal Ig mutation frequencies in
all cases (Weller et al., submitted). The role of TLR9 thus
appears facultative, pointing to the role of other TLRs, like
possibly the B cell-speciﬁc TLR10, in this deﬁcit. The fact
that this deﬁcit was not compensated as patients aged,
suggest a role of TLRs in the speciﬁc homeostatic main-
tenance of IgM
?IgD
?CD27
? B cells. Interestingly, it also
indicates that, in spite of the recent implication of MyD88
in a TACI-mediated isotype switch process, MyD88- or
IRAK4-deﬁciency does not impact the peripheral pool of
IgG
? and IgA
? memory B cells in vivo [52].
Distinct repertoire features revealed by
a deep-sequencing analysis of the different
B cell subsets from adult blood
A high throughput analysis of VH sequences from blood
samples of three adult donors was reported recently [53].
No clonal relationships were found among 1700 sequences
from IgM
?IgD
?CD27
? B cells and 2,000 from switched
IgG
? and IgA
? B cells. Even though the sample size
analyzed was very large, this sequencing obviously lacked
the sensitivity of the approach developed by R. Ku ¨ppers
and colleagues. Nevertheless, clonal relationships within
each subset were recurrently found, with larger and more
frequent clonal ampliﬁcations among switched B cells. The
most striking difference observed concerned the VH rep-
ertoire, with a distinct VH usage affecting most importantly
the VH1 and VH3 families: a twofold higher ratio for the
VH3 and a 20-fold lower ratio for VH1 for
IgM
?IgD
?CD27
? B cells compared to switched cells.
Such a marked VH bias, together with other minor differ-
ences, indicates a minima that different selective forces are
shaping the repertoire of these two subsets.
A human B1 cell compartment?
A newcomer among human B cell subsets is the B1 cell
compartment, a long-searched equivalent of the mouse B1
cell lineage present in the spleen and the peritoneal cavity
and which is responsible for most of the spontaneous IgM
production in this species. This subset, identiﬁed through
the CD43 marker, and being IgD
?CD27
?, displayed B1
cell characteristics, i.e., spontaneous BCR tonic signaling,
a low level of spontaneous IgM plasmocyte production,
and a capacity to drive allogenic T cell proliferation [54].
Curiously enough, this subset was shown to comprise
1632 C.-A. Reynaud et al.
123around 40 % of CD27
? B cells in adults, while declining in
the elderly, a proportion quite similar to the one of
IgM
?IgD
?CD27
? cells. These ﬁgures raised the question
as to whether B1 cells and IgM
?IgD
?CD27
? B cells were
simply superimposable, which would have united the
human equivalent of mouse circulating B1 and splenic
marginal zone B cells in the IgM
?IgD
?CD27
? compart-
ment as a unique subset with innate-like properties [55,
56]. However, serious concerns have been formulated
recently about the effective size of this human B1 popu-
lation, and, consequently about its intrinsic properties
[57, 58].
In conclusion, marginal zone, IgM memory, or B1 B
cells? Major differences between classical memory and
IgM
?IgD
?CD27
? B cells remain, concerning mainly their
ontogeny and the signals mediating their selection/survival.
Later on in adult life, the identity and possible heteroge-
neity of the IgM
?IgD
?CD27
? subset, be it in blood or in
spleen, obviously appears as an unsettled issue.
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